Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

NCT00343512 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped closed due to competing neoadjuvant studies for a small patient population

Conditions

Breast Cancer

Interventions

DRUG: docetaxel
GENETIC: protein expression analysis
OTHER: laboratory biomarker analysis
PROCEDURE: biopsy
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]